First Ever Investigational 18F-CD8 PET Radiopharmaceutical Aims to Predict and Monitor Early…
Article content CHALFONT ST. GILES, England — With immunotherapy emerging as one of the most important treatment options in oncology, GE HealthCare has today announced the first patient scanned in a Phase I clinical trial2 of a…